SCHEMBL716305

SCHEMBL716305

CCCC(O)c1nc(N)c2ncn(C)c2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.57
ADORA1 P30542 3/20 0.57
CDK1 P06493 5/20 0.50
CCNB1 P14635 3/20 0.39
CCNE1 P24864 3/20 0.39
CDK2 P24941 3/20 0.39
ADORA2B P29275 1/20 0.38
ADA P00813 4/20 0.38
PDE2A O00408 3/20 0.38
CYP3A4 P08684 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL715815 0.83 ADORA2A (0.43) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL18165669 0.77 CDK1 (0.60) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL715214 0.75 ADORA2A (0.64) ADORA2AADORA1ADORA2B
SCHEMBL8647735 0.73 CDK1 (0.48) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL411463 0.73 ADORA2A (1.00) ADORA2AADORA1ADORA2B
SCHEMBL380389 0.72 ADORA2A (0.57) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL12417532 0.71 CDK1 (0.60) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL129640 0.71 CDK1 (0.64) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL129642 0.70 CDK1 (0.68) ADORA2AADORA1CDK1CCNB1CCNE1
SCHEMBL29389422 0.70 CDK1 (0.54) ADORA2AADORA1CDK1CCNB1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160002244-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2016-01-07 US disclosed
US-9133197-B2 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2015-09-15 US disclosed
EP-2408775-B1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS SIGMA TAU IND FARMACEUTI (IT) 2015-06-17 EP disclosed
US-20120053191-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ALFASIGMA S.P.A. (IT) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053191-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ADORA2A, ADORA3, ADORA1 ADORA2A 1/4885ADORA1 3/4885CDK1 720/4885
US-20160002244-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ADORA2A, ADORA3, ADORA1 ADORA2A 1/4885ADORA1 3/4885CDK1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.